ACADIA Pharmaceuticals's total assets for Q3 2024 were $976.87M, an increase of 6.87% from the previous quarter. ACAD total liabilities were $399.69M for the fiscal quarter, a 0.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.